Non-specific immunological effects of selected routine childhood immunisations: Systematic review

BMJ (Online)

Volumn 355, Issue , 2016, Pages

  Kandasamy, Rama ^a,b   Voysey, Merryn ^a,b   McQuaid, Fiona ^a,b   De Nie, Karlijn ^a,b   Ryan, Rebecca ^a,b   Orr, Olivia ^a,b   Uhlig, Ulrike ^a   Sande, Charles ^a,b   O'Connor, Daniel ^a,b   Pollard, Andrew J ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DIPHTHERIA VACCINE; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; TETANUS TOXOID; TUMOR NECROSIS FACTOR; DIPHTHERIA PERTUSSIS TETANUS VACCINE; MEASLES VACCINE;

CANDIDA ALBICANS; CASE CONTROL STUDY; CHILD HEALTH CARE; COHORT ANALYSIS; CYTOKINE PRODUCTION; HEALTH CARE POLICY; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL PROCEDURES; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; NONHUMAN; NONSPECIFIC IMMUNOLOGICAL EFFECT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STAPHYLOCOCCUS AUREUS; SYSTEMATIC REVIEW; TREND STUDY; COMMUNICABLE DISEASE CONTROL; DIPHTHERIA; FEMALE; IMMUNOLOGY; INFANT; MALE; MEASLES; ORGANIZATION AND MANAGEMENT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS; STATISTICS AND NUMERICAL DATA; TETANUS; TUBERCULOSIS; UNITED KINGDOM; VACCINATION; WHOOPING COUGH;

BCG VACCINE; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; DIPHTHERIA; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HUMANS; IMMUNIZATION; INFANT; MALE; MEASLES; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TETANUS; TUBERCULOSIS; UNITED KINGDOM; VACCINATION; WHOOPING COUGH;

EID: 84991690456     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i5225     Document Type: Review

References (59)

1. Aaby P, Kollmann TR, Benn CS. Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges. Nat Immunol 2014;15:895-9. doi:10.1038/ni.2961.
2. Benn CS, Netea MG, Selin LK, Aaby P. A small jab - a big effect: nonspecific immunomodulation by vaccines. Trends Immunol 2013;34:431-9. doi:10.1016/j.it.2013.04.004.
3. Aaby P, Benn C, Nielsen J, Lisse IM, Rodrigues A, Ravn H. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open 2012;2:e000707. doi:10.1136/ bmjopen-2011-000707.
4. Aaby P, Ravn H, Roth A, et al. Early diphtheria-tetanus-pertussis vaccination associated with higher female mortality and no difference in male mortality in a cohort of low birthweight children: an observational study within a randomised trial. Arch Dis Child 2012;97:685-91. doi:10.1136/archdischild-2011-300646.
5. Vaugelade J, Pinchinat S, Guiella G, Elguero E, Simondon F. Non-specific effects of vaccination on child survival: prospective cohort study in Burkina Faso. BMJ 2004;329:1309. doi:10.1136/ bmj.38261.496366.82.
6. Krishnan A, Srivastava R, Dwivedi P, Ng N, Byass P, Pandav CS. Non-specific sex-differential effect of DTP vaccination may partially explain the excess girl child mortality in Ballabgarh, India. Trop Med Int Health 2013;18:1329-37. doi:10.1111/tmi.12192.
7. Pollard AJ. Non-specific effects of vaccines: RCTs, not observational studies, are needed. Arch Dis Child 2012;97:677-8. doi:10.1136/ archdischild-2012-301873.
8. Farrington CP, Firth MJ, Moulton LH, Ravn H, Andersen PK, Evans S. Working Group on Non-specific Effects of Vaccines. Epidemiological studies of the non-specific effects of vaccines: II - methodological issues in the design and analysis of cohort studies. Trop Med Int Health 2009;14:977-85. doi:10.1111/j.1365-3156.2009.02302.x.
9. Rehermann B, Shin E-C. Private aspects of heterologous immunity. J Exp Med 2005;201:667-70. doi:10.1084/jem.20050220.
10. Welsh RM, Fujinami RS. Pathogenic epitopes, heterologous immunity and vaccine design. Nat Rev Microbiol 2007;5:555-63. doi:10.1038/ nrmicro1709.
11. Sørup S, Benn CS, Stensballe LG, Aaby P, Ravn H. Measles-mumpsrubella vaccination and respiratory syncytial virus-associated hospital contact. Vaccine 2015;33:237-45. doi:10.1016/j.vaccine.2014.07.110.
12. Aaby P, Garly M-L, Nielsen J, et al. Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanuspertussis vaccines: Observations from vaccination trials in Guinea-Bissau. Pediatr Infect Dis J 2007;26:247-52. http://www.ncbi. nlm.nih.gov/pubmed/17484223. doi:10.1097/01. inf.0000256735.05098.01.
13. Yokomizo A, Kanimoto Y, Okamura T, et al. Randomized Controlled Study of the Efficacy, Safety and Quality of Life of Low-Dose Bacillus Calmette-Guerin Instillation Therapy for Non-Muscle-Invasive Bladder Cancer. J Urol 2015;195:41-6. doi:10.1016/j.juro.2015.08.075
14. Stewart JH 4th, Levine EA. Role of bacillus Calmette-Guérin in the treatment of advanced melanoma. Expert Rev Anticancer Ther 2011;11:1671-6. doi:10.1586/era.11.163.
15. Nofal A, Nofal E, Yosef A, Nofal H. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach. Int J Dermatol 2015;54:667-71. doi:10.1111/ijd.12480.
16. WHO. SAGE Working Group on non-specific effects of vaccines (March-June 2013). http://www.who.int/immunization/sage/ sage-wg-non-specific-effects-vaccines-march2013/en/
17. WHO. Weekly Epidemiological Record 2008;83,32:285-292. http:// www.who.int/wer/2008/wer8332/en/.
18. WHO. Weekly Epidemiological Record 2014;89,21:221-236. http:// www.who.int/wer/2014/wer8921/en/.
19. Burl S. The Role of Regulatory T cells in Early Life Immunity to BCG: Influence of Exposure to Environmental Mycobacteria.Open University, 2009.
20. Djuardi Y, Sartono E, Wibowo H, Supali T, Yazdanbakhsh M. A longitudinal study of BCG vaccination in early childhood: the development of innate and adaptive immune responses. PLoS One 2010;5:e14066. doi:10.1371/journal.pone.0014066.
21. Faustman DL, Wang L, Okubo Y, et al. Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes. PLoS One 2012;7:e41756. doi:10.1371/ journal.pone.0041756.
22. Kleinnijenhuis J, Quintin J, Preijers F, et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A 2012;109:17537-42. doi:10.1073/pnas.1202870109.
23. Libraty DH, Zhang L, Woda M, et al. Neonatal BCG vaccination is associated with enhanced T-helper 1 immune responses to heterologous infant vaccines. Trials Vaccinol 2014;3:1-5. doi:10.1016/j.trivac.2013.11.004.
24. Marks GB, Ng K, Zhou J, et al. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J Allergy Clin Immunol 2003;111:541-9. doi:10.1067/mai.2003.171.
25. Ota MO, Vekemans J, Schlegel-Haueter SE, et al. Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002;168:919-25. doi:10.4049/jimmunol.168.2.919.
26. Tastan Y, Arvas A, Demir G, Alikasifoglu M, Gür E, Kiray E. Influence of Bacillus Calmette-Guèrin vaccination at birth and 2 months old age on the peripheral blood T-cell subpopulations [gamma/delta and alpha-beta T cell]. Pediatr Allergy Immunol 2005;16:624-9. doi:10.1111/j.1399-3038.2005.00329.x.
27. Vargas MH, Bernal-Alcántara DA, Vaca MA, Franco-Marina F, Lascurain R. Effect of BCG vaccination in asthmatic schoolchildren. Pediatr Allergy Immunol 2004;15:415-20. doi:10.1111/j.1399-3038.2004.00198.x.
28. Vijaya Lakshmi V, Kumar S, Surekha Rani H, Suman LG, Murthy KJ. Tuberculin specific T cell responses in BCG vaccinated children. Indian Pediatr 2005;42:36-40.
29. Weir RE, Black GF, Dockrell HM, et al. Mycobacterial purified protein derivatives stimulate innate immunity: Malawians show enhanced tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-10 responses compared to those of adolescents in the United Kingdom. Infect Immun 2004;72:1807-11. doi:10.1128/IAI.72.3.1807-1811.2004.
30. Hennino A, Cornu C, Rozieres A, et al. Influence of measles vaccination on the progression of atopic dermatitis in infants. Pediatr Allergy Immunol 2007;18:385-90. doi:10.1111/j.1399-3038.2007.00537.x.
31. Hussey GD, Goddard EA, Hughes J, et al. The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune response in infants. J Infect Dis 1996;173:1320-6. doi:10.1093/infdis/173.6.1320.
32. Lisse IM, Aaby P, Knudsen K, Whittle H, Andersen H. Long term impact of high titer Edmonston-Zagreb measles vaccine on T lymphocyte subsets. Pediatr Infect Dis J 1994;13:109-12. doi:10.1097/00006454-199402000-00006.
33. Ovsyannikova IG, Reid KC, Jacobson RM, Oberg AL, Klee GG, Poland GA. Cytokine production patterns and antibody response to measles vaccine. Vaccine 2003;21:3946-53. doi:10.1016/S0264-410X(03)00272-X.
34. Samb B, Whittle H, Aaby P, et al. No evidence of long-term immunosuppression after high-titer Edmonstron-Zagreb measles vaccination in Senegal. J Infect Dis 1995;171:506-8. doi:10.1093/ infdis/171.2.506.
35. Schnorr JJ, Cutts FT, Wheeler JG, et al. Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants. Vaccine 2001;19:1503-10. doi:10.1016/S0264-410X(00)00349-2.
36. Pabst HF, Spady DW, Carson MM, Stelfox HT, Beeler JA, Krezolek MP. Kinetics of immunologic responses after primary MMR vaccination. Vaccine 1997;15:10-4. doi:10.1016/S0264-410X(96)00124-7.
37. Rager-Zisman B, Bazarsky E, Skibin A, et al. The effect of measlesmumps-rubella (MMR) immunization on the immune responses of previously immunized primary school children. Vaccine 2003;21:2580-8. doi:10.1016/S0264-410X(03)00053-7.
38. Armitage KB, Duffy EG, Mincek MA, et al. Transient normalization of lymphocyte blastogenic and specific antibody responses following boosting of healthy elderly subjects with tetanus toxoid. J Gerontol 1993;48:M19-25. doi:10.1093/geronj/48.1.M19.
39. Borut TC, Ank BJ, Gard SE, Stiehm ER. Tetanus toxoid skin test in children: correlation with in vitro lymphocyte stimulation and monocyte chemotaxis. J Pediatr 1980;97:567-73. doi:10.1016/ S0022-3476(80)80010-2.
40. Chollet P, Chassagne J, Philippe P, et al. Peripheral lymphocytes changes in the anamnestic response to tetanus toxoid challenge. Clin Exp Immunol 1979;37:152-61.
41. Gentile D, Trecki J, Patel A, Fausnight T, Angelini B, Skoner D. Effect of tetanus immunization on t-helper cytokine production in adults with and without allergic rhinitis. Allergy Asthma Proc 2006;27:197-201. doi:10.2500/aap.2006.27.2857.
42. Mahalingam D, Radhakrishnan AK, Amom Z, Ibrahim N, Nesaretnam K. Effects of supplementation with tocotrienol-rich fraction on immune response to tetanus toxoid immunization in normal healthy volunteers. Eur J Clin Nutr 2011;65:63-9. doi:10.1038/ejcn.2010.184.
43. Fernandes JR, Wasserman S, Snider DP. Stimulation of anti-polio and anti-HSV IgA pre-plasma cell response in blood following parenteral immunization with tetanus-diphtheria vaccine. Vaccine 2010;28:1493-8. doi:10.1016/j.vaccine.2009.11.057.
44. Halasa NB, O'Shea A, Shi JR, LaFleur BJ, Edwards KM. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 2008;153:327-32. doi:10.1016/j.jpeds.2008.03.011.
45. Heine G, Drozdenko G, Lahl A, et al. Efficient tetanus toxoid immunization on vitamin D supplementation. Eur J Clin Nutr 2011;65:329-34. doi:10.1038/ejcn.2010.276.
46. Rowe J, Macaubas C, Monger TM, et al. Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized. Infect Immun 2000;68:3873-7. doi:10.1128/ IAI.68.7.3873-3877.2000.
47. El Yousfi M, Mercier S, Breuillé D, et al. The inflammatory response to vaccination is altered in the elderly. Mech Ageing Dev 2005;126:874-81. doi:10.1016/j.mad.2005.03.008.
48. Hoft DF, Brown RM, Roodman ST. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J Immunol 1998;161:1045-54.
49. Jorgensen MJ, Fisker AB, Sartono E, et al. The effect of at-birth vitamin A supplementation on differential leucocyte counts and in vitro cytokine production: an immunological study nested within a randomised trial in Guinea-Bissau. Br J Nutr 2013;109:467-77. doi:10.1017/S0007114512001304.
50. Di Tommaso A, Bartalini M, Peppoloni S, Podda A, Rappuoli R, De Magistris MT. Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults. Vaccine 1997;15:1218-24. doi:10.1016/S0264-410X(97)00023-6.
51. Kollmann TR, Levy O, Montgomery RR, Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 2012;37:771-83. doi:10.1016/j.immuni.2012.10.014.
52. MacKaness GB. The Immunological Basis of Acquired Cellular Resistance. J Exp Med 1964;120:105-20. doi:10.1084/jem.120.1.105.
53. Saeed S, Quintin J, Kerstens HH, et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 2014;345:1251086. doi:10.1126/science.1251086.
54. Choi IS, Lin XH, Koh YA, Koh YI, Lee HC. Strain-dependent suppressive effects of BCG vaccination on asthmatic reactions in BALB/c mice. Ann Allergy Asthma Immunol 2005;95:571-8. doi:10.1016/ S1081-1206(10)61021-6.
55. Parra M, Liu X, Derrick SC, et al. Molecular analysis of non-specific protection against murine malaria induced by BCG vaccination. PLoS One 2013;8:e66115. doi:10.1371/journal.pone.0066115.
56. Nakaya HI, Wrammert J, Lee EK, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011;12:786-95. doi:10.1038/ni.2067.
57. Gaucher D, Therrien R, Kettaf N, et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008;205:3119-31. doi:10.1084/jem.20082292.
58. Mejias A, Ramilo O. Transcriptional profiling in infectious diseases: ready for prime time? J Infect 2014;68(Suppl 1):S94-9. doi:10.1016/j. jinf.2013.09.018.
59. Kalina T, Flores-Montero J, Lecrevisse Q, et al. Quality assessment program for EuroFlow protocols: summary results of four-year (2010-2013) quality assurance rounds. Cytometry A 2015;87:145-56. doi:10.1002/cyto.a.22581.